
|Videos|December 10, 2020
Jelmyto for low-grade UTUC: Clinical experience and side effects to watch for
Author(s)Urology Times staff
Angela B. Smith, MD, MS, describes her institution’s early clinical experience with mitomycin-containing reverse thermal gel (Jelmyto).
Advertisement
In this video, Angela B. Smith, MD, MS, also outlines side effects of Jelmyto that urologists should watch for. Smith is vice chair of academic affairs, director of urologic oncology, and associate professor of urology at UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study launches of MRI plus PSMA-PET imaging for prostate cancer detection
2
CREST and POTOMAC: Redefining immunotherapy’s role in NMIBC
3
Initial ARID results published in World Journal of Urology as pivotal trial progresses
4
New Data Influencing your Treatment Decisions in mCSPC
5



















